Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging

NCT03303469 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped study was terminated due to poor enrollment

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: FMISO
DRUG: FMISO
DRUG: FMISO

Sponsor

University of Alabama at Birmingham